AuBEX CORPORATION (TYO:3583)
Japan · Delayed Price · Currency is JPY 1,329.00
-28.00 (-2.06%)
Jul 24, 2026, 1:16 PM JST
AuBEX CORPORATION Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 6,015 | 6,015 | 6,035 | 5,387 | 5,315 | 5,486 |
Revenue Growth | -0.33% | -0.33% | 12.03% | 1.35% | -3.12% | 15.47% |
Gross Profit Gross Profit Growth | 2,008 | 2,008 | 2,293 | 1,876 | 1,879 | 1,963 |
Operating Income Operating Income Growth | 616 | 616 | 841 | 561 | 623 | 707 |
Net Income Net Income Growth | 573 | 573 | 580 | 436 | 469 | 536 |
Earnings Per Share EPS Growth | 208.93 | 208.93 | 209.00 | 156.65 | 169.10 | 193.86 |
EPS Growth | -0.03% | -0.03% | 33.42% | -7.36% | -12.77% | 369.92% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Medical Product Business Medical Product Business Growth | 1,783 | 1,783 | 1,702 | 1,592 | 1,425 | 1,416 |
Techno Product Business Techno Product Business Growth | 4,236 | 4,236 | 4,335 | 3,796 | 3,894 | 4,073 |
Unallocated Adjustment Unallocated Adjustment Growth | -4.02 | -4.02 | -1.18 | -0.86 | -28.27 | -16.05 |
Total Total Growth | 6,015 | 6,015 | 6,036 | 5,387 | 5,315 | 5,486 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,627 | 2,627 | 2,850 | 2,952 | 2,476 | 2,499 |
Total Debt Total Debt Growth | 1,520 | 1,520 | 1,489 | 1,838 | 2,196 | 2,330 |
Net Cash (Debt) Net Cash Growth | 1,107 | 1,107 | 1,361 | 1,114 | 280 | 169 |
Net Cash Growth | -18.66% | -18.66% | 22.17% | 297.86% | 65.68% | - |
Net Cash Per Share Net Cash Per Share Growth | 403.64 | 403.64 | 490.43 | 400.24 | 100.95 | 61.12 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 329 | 329 | 637 | 1,054 | 338 | 1,000 |
Capital Expenditures CapEx Growth | -439 | -439 | -173 | -143 | -270 | -164 |
Free Cash Flow Free Cash Flow Growth | -110 | -110 | 464 | 911 | 68 | 836 |
Free Cash Flow Growth | - | - | -49.07% | 1239.71% | -91.87% | 87.02% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 33.38% | 33.38% | 38.00% | 34.83% | 35.35% | 35.78% |
Operating Margin | 10.24% | 10.24% | 13.94% | 10.41% | 11.72% | 12.89% |
Pretax Margin | 10.56% | 10.56% | 13.55% | 11.12% | 12.79% | 13.22% |
Profit Margin | 9.53% | 9.53% | 9.61% | 8.09% | 8.82% | 9.77% |
FCF Margin | -1.83% | -1.83% | 7.69% | 16.91% | 1.28% | 15.24% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 35.000 | 35.000 | 28.000 | 20.000 | 20.000 | 15.000 |
Dividend Per Share Growth | 6.06% | 25.00% | 40.00% | 0% | 33.33% | 0% |
Dividend Yield | 2.63% | 2.63% | 2.05% | 2.15% | 2.09% | 1.80% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 6.36 | 6.35 | 6.66 | 6.24 | 6.09 | 4.72 |
P/FCF Ratio | - | - | 8.32 | 2.98 | 41.98 | 3.03 |
PS Ratio | 0.61 | 0.61 | 0.64 | 0.51 | 0.54 | 0.46 |